Hematologic Effects of Linezolid: Summary of Clinical Experience

Linezolid has been associated with reversible myelosuppression. Clinical trial data were evaluated for anemia, thrombocytopenia, and neutropenia. Thrombocytopenia and a slight increased risk for anemia were evident at ≥2 weeks of linezolid treatment. Hematologic abnormalities were consistent with mi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Gerson, Stanton L., Kaplan, Sheldon L., Bruss, Jon B., Le, Vu, Arellano, Felix M., Hafkin, Barry, Kuter, David J.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2002
Témata:
Clinical Therapeutics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC127358/
https://ncbi.nlm.nih.gov/pubmed/12121967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.46.8.2723-2726.2002
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky